Search

Author/Creator Braiteh, Fadi S.

1. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015)

Authors:
Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le...
Journal:
European journal of cancer
Issue:
Volume 51:Issue 14(2015:Sep.)
Page Start:
1857
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015)

Authors:
Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le...
Journal:
European journal of cancer
Issue:
Volume 51:Issue 14(2015:Sep.)
Page Start:
1857
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI. Issue 3 (September 2015)

Authors:
Klempner, Samuel J.; Bazhenova, Lyudmila A.; Braiteh, Fadi S.; Nikolinakos, Petros G.; Gowen, Kyle; Cervantes, Claudia M.; Chmielecki, Juliann; Greenbowe, Joel R; Ross, Jeffrey S.; Stephens, Philip J.; Miller, Vincent A.; Ali, Siraj M.; Ou, Sai-Hong Ignatius
Journal:
Lung cancer
Issue:
Volume 89:Issue 3(2015:Sep.)
Page Start:
357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial. (December 2018)

Authors:
Chen, Li-Tzong; Siveke, Jens T.; Wang-Gillam, Andrea; Li, Chung-Pin; Bodoky, György; Dean, Andrew P.; Shan, Yan-Shen; Jameson, Gayle S.; Macarulla, Teresa; Lee, Kyung-Hun; Cunningham, David; Blanc, Jean-Frédéric; Chiu, Chang-Fang; Schwartsmann, Gilberto; Braiteh, Fadi S.; Mamlouk, Khalid; Belange...
Journal:
European journal of cancer
Issue:
Volume 105(2018)
Page Start:
71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗